Author archive
By MICHAEL MILLENSON I could’ve been Kamala Harris, Joe Biden and Marianne Williamson all rolled into one. That’s how I might have handled my first, only, and not-so-great presidential debate. No, IContinue reading…
In September, 2008, the campaign asked me to serve as a surrogate in a debate with John McCain’s health care adviser when one of Obama’s close advisers – as opposed to me, who’d met the candidate once at a campaign event – couldn’t make it.
Though a record $8.1 billion poured into digital health firms in 2018, the marketplace is far from welcoming to every new entrant. A parade of entrepreneurs, investors and health tech purchasers at a recent MedCity INVEST conference described the reali…
The largest health data steward “on the planet,” the Department of Health and Human Services, plans to make its data releases actionable for entrepreneurs and patients. The clinical and economic impact of this connected health information could be enor…
By MICHAEL L. MILLENSON Say you want to know which baseball players provide the most value for the big dollars they’re being paid. A Google search quickly yields analytics. But suppose your primaryContinue reading…
By MICHAEL L. MILLENSON Say you want to know which baseball players provide the most value for the big dollars they’re being paid. A Google search quickly yields analytics. But suppose your primaryContinue reading…
By MICHAEL L. MILLENSON Say you want to know which baseball players provide the most value for the big dollars they’re being paid. A Google search quickly yields analytics. But suppose your primary care physician just diagnosed you with cancer. What will a search for a “high value” cancer doctor tell you? Not much. Public concern over
By MICHAEL MILLENSON Abbott Ventures chief Evan Norton may have spent part of his youth on a farm, but there’s no manure in his manner when speaking of the medical device and diagnostics market landscape.Continue reading…
By MICHAEL MILLENSON Abbott Ventures chief Evan Norton may have spent part of his youth on a farm, but there’s no manure in his manner when speaking of the medical device and diagnostics market landscape.Continue reading…
By MICHAEL MILLENSON Abbott Ventures chief Evan Norton may have spent part of his youth on a farm, but there’s no manure in his manner when speaking of the medical device and diagnostics market landscape. The key, he says, is to avoid being blindsided by the transformational power of digital data. “We’ve been competing against Medtronic and J&J,